JAK/STAT signaling in hepatocellular carcinoma

Liver cancer is the second most lethal cancer in the world with limited treatment options. Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has had increasing global incidence over the past few years. There is an urgent need for novel and better therapeutic inte...

全面介紹

書目詳細資料

發表在:	Hepatic Oncology
Main Authors:	Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, Tan Boon Toh
格式:	Article
語言:	英语
出版:	Taylor & Francis 2020-03-01
主題:	hepatocarcinogenesis hepatocellular carcinoma JAK/STAT signaling liver cancer targeted therapy
在線閱讀:	https://www.futuremedicine.com/doi/10.2217/hep-2020-0001